
Our Experience list is sortable by client, brand name, (127) USAN/INN name, and therapeutic category:
Sort Clients By: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z || ALL
|
|
|
|
| JANSSEN | DORIBAX | Antibiotic | | JANSSEN | INTELENCE * | Antiviral/HIV | | JANSSEN | INVEGA * | Neurology | | JANSSEN | INVEGA SUSTENNA | Neurology | | JANSSEN | PREZISTA * | Antiviral/HIV | | JANSSEN | YONDELIS * | Oncology | | JANSSEN | ZEFTERA | Antibiotic | | JANSSEN-CILAG | JURNISTA * | Pain & Inflammation | | JANSSEN-CILAG | PRILIGY | Premature Ejaculation Treatment | | JAZZ PHARMACEUTICALS | ELPETRIGINE | Neurology | | JOHNSON & JOHNSON | ACIPHEX | Gastrointestinal | | JOHNSON & JOHNSON | ACUVUE 2 | Ophthalmology | | JOHNSON & JOHNSON | ACUVUE ADVANCE WITH HYDRACLEAR | Ophthalmology | | JOHNSON & JOHNSON | ANGIOGUARD | Medical Device | | JOHNSON & JOHNSON | ARHALOFENATE | Endocrinology | | JOHNSON & JOHNSON | BAVISANT | Neurology | | JOHNSON & JOHNSON | BEDAQUILINE | Antibiotic | | JOHNSON & JOHNSON | CANAGLIFLOZIN | Endocrinology | | JOHNSON & JOHNSON | CARISBAMATE | Neurology | | JOHNSON & JOHNSON | DEFINITY 2 | Ophthalmology | | JOHNSON & JOHNSON | DERMABOND | Medical Device | | JOHNSON & JOHNSON | DORIBAX | Antibiotic | | JOHNSON & JOHNSON | DUAL-PAK | Medical Device | | JOHNSON & JOHNSON | EVOLENCE | Dermatology | | JOHNSON & JOHNSON | IMUCLONE | Medical Device | | JOHNSON & JOHNSON | INTELENCE * | Antiviral/HIV | | JOHNSON & JOHNSON | INTETUMUMAB | Oncology | | JOHNSON & JOHNSON | INVEGA * | Neurology | | JOHNSON & JOHNSON | INVEGA | Identity Research | | JOHNSON & JOHNSON | INVEGA SUSTENNA | Identity Research | | JOHNSON & JOHNSON | INVEGA SUSTENNA | Neurology | | JOHNSON & JOHNSON | M-TAB | Medical Device | | JOHNSON & JOHNSON | MONISTAT 3, 7 | Antifungal | | JOHNSON & JOHNSON | MONISTAT DUAL-PAK | Antifungal | | JOHNSON & JOHNSON | POWERGRIP | Medical Device | | JOHNSON & JOHNSON | PREZISTA * | Antiviral/HIV | | JOHNSON & JOHNSON | RAZADYNE | Neurology | | JOHNSON & JOHNSON | RAZADYNE ER | Neurology | | JOHNSON & JOHNSON | RESOLOR | Gastrointestinal | | JOHNSON & JOHNSON | RILPIVIRINE | Antiviral/HIV | | JOHNSON & JOHNSON | RISPERDAL M-TAB | Neurology | | JOHNSON & JOHNSON | SENICAPOC | Hematology | | JOHNSON & JOHNSON | SERDEMETAN | Oncology | | JOHNSON & JOHNSON | SILTUXIMAB | Oncology | | JOHNSON & JOHNSON | SUREVUE 2 | Ophthalmology | | JOHNSON & JOHNSON | TALMAPIMOD | Oncology | | JOHNSON & JOHNSON | TERAZOL | Antifungal | | JOHNSON & JOHNSON | USTEKINUMAB | Immunology | | JOHNSON & JOHNSON | VELCADE | Oncology | | JOHNSON & JOHNSON | VELOCITY | Medical Device | | JOHNSON & JOHNSON | XARELTO | Hematology |
* Denotes a comprehensive report of the safety regulatory research prepared by BI/DSI for submission of this name candidate to FDA and/or EMEA, and/or Health Canada, and other Regulatory Agencies. |
|
| |